Minerva Neurosciences Inc (NERV) has risen Friday morning, with the stock climbing 5.98% in pre-market trading to 1.95. NERV's short-term technical score of 25 indicates that the stock has traded less bullishly over the last month than 75% of stocks on the market. In the Biotechnology industry, which ranks 139 out of 146 industries, Minerva Neurosciences Inc ranks higher than 53% of stocks. Minerva Neurosciences Inc has fallen 5.64% over the past month, closing at $1.89 on August 27. During this period of time, the stock fell as low as $1.67 and as high as $1.95. NERV has an average analyst recommendation of Buy. The company has an average price target of $6.50.
NERV has an Overall Score of 43. Find out what this means to you and get the rest of the rankings on NERV!